Adjunctive treatment with high-titre convalescent plasma in severely and critically ill COVID-19 patients – a safe but futile intervention. A comparative cohort study

BACKGROUND: Convalescent plasma (CP) containing antibodies derived from coronavirus disease 2019 (COVID-19) survivors has been proposed as a promising therapeutic option for severe COVID-19. METHODS: In our intensive care unit (ICU), 55 patients (46 male, median age 61 years) with PCR-confirmed COVI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Dis (Lond)
Main Authors: Hoepler, Wolfgang Paul, Weidner, Lisa, Traugott, Marianna Theresia, Neuhold, Stephanie, Meyer, Elias Laurin, Zoufaly, Alexander, Seitz, Tamara, Kitzberger, Reinhard, Baumgartner, Sebastian, Pawelka, Erich, Karolyi, Mario, Grieb, Alexander, Hind, Julian, Laferl, Hermann, Friese, Emanuela, Wenisch, Christoph, Aberle, Stephan Walter, Aberle, Judith Helene, Weseslindtner, Lukas, Jungbauer, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220442/
https://ncbi.nlm.nih.gov/pubmed/34128763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23744235.2021.1940271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados